Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS)
CNY 21.63
(-0.18%)
CNY 21.63
(-0.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 438.72 Million | 233.49 Million | -243.79 Million | -40.07 Million | 587.63 Million | 361.28 Million |
| Net Income | 294.61 Million | 45.43 Million | -1.69 Million | -235.81 Million | 210.04 Million | 357.96 Million |
| Depreciation & Amortization | 96.08 Million | 122.41 Million | 135.45 Million | 136.01 Million | 132.16 Million | 120.13 Million |
| Deferred income taxes | 27.27 Million | -16.47 Million | -2.49 Million | 62 Million | -19.07 Million | 4.32 Million |
| Stock-based compensation | -6.28 Million | 2.54 Million | 11.41 Million | 509.49 Thousand | 108.82 Million | 1.74 Million |
| Change in working capital | 106.75 Million | 79.59 Million | -366.76 Million | 2.73 Million | 198.93 Million | -68.79 Million |
| Other non-cash items | -79.72 Million | -8988.00 | -19.7 Million | -5.53 Million | -43.26 Million | -54.09 Million |
| Investing Cash Flow | -501.79 Million | -916.69 Million | -18.5 Million | -529.59 Million | 369.25 Million | -266.72 Million |
| Investments in PPE | -235.74 Million | -221.26 Million | -263.82 Million | -226.98 Million | -130.24 Million | -90.05 Million |
| Acquisitions | 100.45 Million | 401.7 Thousand | 378 Thousand | 27.11 Thousand | 130.24 Million | - |
| Investment purchases | -3.51 Billion | -6.04 Billion | -3.48 Billion | -3.82 Billion | -6.12 Billion | -2.9 Billion |
| Sales/Maturities of investments | 3.14 Billion | 5.34 Billion | 3.73 Billion | 3.51 Billion | 6.62 Billion | 2.72 Billion |
| Other Investing Activities | -243.67 Million | 0.89 | 0.90 | 8.91 Million | -130.24 Million | 119.53 Thousand |
| Financing Cash Flow | -101.47 Million | 151.07 Million | 0.31 | 1.86 Billion | -672.12 Million | -3 Million |
| Debt repayment | -100 Million | -150 Million | - | - | - | - |
| Dividends payments | -1.47 Million | -1.22 Million | - | - | -716.49 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.47 Million | 302.29 Million | - | 1.86 Billion | 44.36 Million | -3 Million |
| Accounts receivables | 15.39 Million | 107.09 Million | -258.94 Million | 196.62 Million | 260.72 Million | -70.26 Million |
| Accounts payables | 63.45 Million | 9.23 Million | -67.48 Million | -34.82 Million | 3.9 Million | 23.54 Million |
| Inventory | 33.35 Million | -20.26 Million | 11.38 Million | -109.05 Million | -53.31 Million | -22.73 Million |
| Other working capital | -5.45 Million | -16.47 Million | -51.71 Million | -50.01 Million | -12.37 Million | -46.06 Million |
| Cash at beginning of period | 1.09 Billion | 1.5 Billion | 1.77 Billion | 488.86 Million | 202.04 Million | 107.57 Million |
| Cash at end of period | 933.26 Million | 977.14 Million | 1.5 Billion | 1.77 Billion | 488.86 Million | 202.04 Million |
| Capital Expenditure | -235.74 Million | -221.26 Million | -263.82 Million | -226.98 Million | -130.24 Million | -90.05 Million |
| Effect of forex changes on cash | 2.27 Million | 1.46 Million | -173.52 Thousand | -13.24 Million | 2.05 Million | 2.91 Million |
| Net cash flow / Change in cash | -157.45 Million | -530.65 Million | -262.46 Million | 1.28 Billion | 286.81 Million | 94.47 Million |
| Free Cash Flow | 202.97 Million | 12.23 Million | -507.61 Million | -267.06 Million | 457.39 Million | 271.22 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 103.53 Million | 38.39 Million | 91.11 Million | 130.69 Million | 294.61 Million | 69.16 Million |
| Depreciation & Amortization | - | 32.49 Million | 32.49 Million | 18.71 Million | 96.08 Million | -58.35 Million |
| Deferred income taxes | -14.08 Million | - | - | 16.15 Million | 27.27 Million | 95.23 Million |
| Stock-based compensation | - | - | - | -3.54 Million | -6.28 Million | -3.54 Million |
| Change in working capital | - | -51.77 Million | - | -12.61 Million | 106.75 Million | -40.62 Million |
| Other non-cash items | 403.56 Million | 42.63 Million | 13.98 Million | -1.12 Million | -79.72 Million | 66.98 Million |
| Investing Cash Flow | -104.04 Million | -38.78 Million | -411.07 Million | -408.85 Million | -501.79 Million | 3.05 Million |
| Investments in PPE | -61.05 Million | -62.27 Million | -55.15 Million | 369.64 Thousand | -235.74 Million | -49.21 Million |
| Acquisitions | 570.1 Thousand | 35 Thousand | - | 99.29 Million | 100.45 Million | 0.01 |
| Investment purchases | -1.5 Billion | -878.28 Million | -619 Million | -901.28 Million | -3.51 Billion | -543.1 Million |
| Sales/Maturities of investments | 1.45 Billion | 901.73 Million | 263.07 Million | 392.75 Million | 3.14 Billion | 595.37 Million |
| Other Investing Activities | 570.1 Thousand | 31.87 Million | -350.83 Million | 1.00 | -243.67 Million | -174.17 Million |
| Financing Cash Flow | -20.62 Million | -31.15 Million | -309.7 Thousand | -309.68 Thousand | -101.47 Million | -285.83 Thousand |
| Debt repayment | - | - | - | - | -100 Million | - |
| Dividends payments | -20.62 Million | -31.15 Million | -309.7 Thousand | -309.68 Thousand | -1.47 Million | -285.83 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -20.62 Million | -31.15 Million | -309.7 Thousand | 0.89 | -1.47 Million | - |
| Accounts receivables | - | -58.22 Million | - | -13.97 Million | 15.39 Million | -43.35 Million |
| Accounts payables | - | - | - | - | 63.45 Million | - |
| Inventory | - | 6.44 Million | - | 1.36 Million | 33.35 Million | 2.73 Million |
| Other working capital | - | - | - | - | -5.45 Million | - |
| Cash at beginning of period | 487.23 Million | 627.97 Million | 933.26 Million | 1.2 Billion | 1.09 Billion | 956.84 Million |
| Cash at end of period | 405.05 Million | 608.34 Million | 627.97 Million | 933.26 Million | 933.26 Million | 1.09 Billion |
| Capital Expenditure | -61.05 Million | -62.27 Million | -55.15 Million | 369.64 Thousand | -235.74 Million | -49.21 Million |
| Effect of forex changes on cash | -44.4 Thousand | 64.9 Thousand | -15.5 Thousand | 862.88 Thousand | 2.27 Million | -163.49 Thousand |
| Net cash flow / Change in cash | -82.17 Million | -19.62 Million | -305.29 Million | -274.82 Million | -157.45 Million | 134.2 Million |
| Free Cash Flow | 431.96 Million | -13.74 Million | 49.95 Million | 132.49 Million | 202.97 Million | 82.38 Million |
0043
SPLPETRO
ENADF
CYIENTDLM
LVH
OCINF